TICKERNERD
Menu
PASWPASWConsumer Cyclical · Textile Manufacturing

PASW Stock Forecast: Ping An Biomedical Co., Ltd. Price Predictions for 2026-2027

Last close, 21 Oct 2026
$0.09
−26.40% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 2 of 100 as at 21 Oct 2026 — in the weakest quartile.

Market cap
$15.6M
Ticker Nerd rank
2/ 100
Median analyst target
—
Analysts covering
—
Total return, dividends reinvested
1W
−22.0%
1M
−31.9%
YTD
−81.7%
1Y
−87.6%
From 52W high
−87.8%
From 52W low
0.0%
$0.09
$0.76
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

PASW stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Ping An Biomedical Co., Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Oct 2026
2/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
91
Revisions
25
Momentum
15
Volatility
10
Accruals
8
Growth
5
Issuance
4
Quality
4
Value
4

Size (91): Smaller than most of the companies we track.

Value (4): The shares cost a lot relative to the profits and assets behind them.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

PASW stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on PASW, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.00$0.20$0.40$0.60$0.80Jan 26Apr 26Jul 26Oct 26PASW

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

PASW appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.
  • The AI build-out, every Wednesday: how AI stocks did, part by part.

Free. Unsubscribe any time.

Performance

PASW vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 21 Oct 2026, Ping An Biomedical Co., Ltd. returned −87.6% against +16.4% for the S&P 500, dividends included.

PASW vs S&P 500, last 12 monthsTotal return, rebased to 100
020406080100120Jan 26Apr 26Jul 26Oct 26PASWS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

PASW analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Ping An Biomedical Co., Ltd. (PASW) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
0.4×

Cheaper than 83% of US stocks

Price / book
1.0×

Cheaper than 72% of US stocks

EV / EBITDA
−1.8×

Cheaper than 73% of US stocks

Growth & margins
Revenue growth (YoY)
−47.4%

Higher than 6% of US stocks

Earnings growth (YoY)
—
Gross margin
—
Operating margin
5.6%

Higher than 56% of US stocks

Net margin
−14.8%

Higher than 17% of US stocks

Returns & dividend
Return on equity
−11.4%

Higher than 35% of US stocks

Return on assets
−8.9%

Higher than 28% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Ping An Biomedical Co., Ltd. (PASW) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Ping An Biomedical Co., Ltd. has a market value of $15.6M and an enterprise value of $2.9M.

  • Shares outstanding: 20.5M.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Ping An Biomedical Co., Ltd. employs 7 people.

market figures as at 21 Oct 2026

Data provided by Twelve Data

Peers

PASW vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelTextile Manufacturing
CompanyMarket capTKN rank
PASWPing An Biomedical Co., Ltd.$15.6M2
CULPCulp, Inc.$45.7M78
SMJFSMJ International Holdings, Inc.$47.3M1
UFIUnifi, Inc.$101.2M66
ASBPAspire-Lakewood Holdings, Inc.*$12.4M17
BTBDBT Brands, Inc.*$10.5M63
PRPLPurple Innovation, Inc.*$10.2M53

* Nearest Consumer Cyclical names by size — few textile manufacturing companies of this scale trade in the US universe.

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Ping An Biomedical Co., Ltd. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest PASW news & analysis

Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property Portfolio

GlobeNewsWire · 22 Oct 2026positive

Ping An Biomedical entered a letter of intent with Future Biotechnology Group for the planned acquisition of three tumor cell-related medical technology patents. The patents cover oncology diagnosis and treatment, cell detection and bioengineering, and biomarker and DNA probe technologies; the stated consideration is US$2 million to US$2.5 million.

Why it matters — A PASW watcher may follow the planned acquisition for its potential to expand the company’s oncology and biotechnology intellectual property portfolio.

Ping An Biomedical Announces 1-for-40 Reverse Stock Split

GlobeNewsWire · 21 Oct 2026neutral

Ping An Biomedical announced that its board approved a 1-for-40 reverse stock split of the company’s Class A and Class B ordinary shares.

Why it matters — PASW watchers may want to note the approved change to the share structure.

FAQ

Frequently asked questions about PASW stock

How does Ticker Nerd's model rank PASW?

As at 21 Oct 2026, Ping An Biomedical Co., Ltd. ranks 2 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (91 of 100).

What is the PASW stock forecast for 2030?

No analyst covering Ping An Biomedical Co., Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for PASW are extrapolating price history, which says nothing about the business.

How has PASW stock performed over the past year?

Ping An Biomedical Co., Ltd. returned -87.6% over the 12 months to 21 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Ping An Biomedical Co., Ltd. do?

Ping An Biomedical Co., Ltd. is a Hong Kong-based company that provides supply chain management services for the apparel industry.

What is the latest news on PASW?

The most recent item we track (GlobeNewsWire, 22 Oct 2026): "Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property Portfolio". Ping An Biomedical entered a letter of intent with Future Biotechnology Group for the planned acquisition of three tumor cell-related medical technology patents. The patents cover oncology diagnosis and treatment, cell detection and bioengineering, and biomarker and DNA probe technologies; the stated consideration is US$2 million to US$2.5 million.

Company

About Ping An Biomedical Co., Ltd.

Ping An Biomedical Co., Ltd. is a Hong Kong-based company that provides supply chain management services for the apparel industry. Its operations cover market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The company also manufactures and trades yarns, textiles, and finished garments, while offering warehousing services and real estate property investment. It serves brand owners, textile manufacturers, apparel sourcing agents, and online fashion retailers across markets in China, Hong Kong, Cambodia, and Europe. Ping An Biomedical Co., Ltd. focuses on integrated, one-stop solutions that connect sourcing, production, and delivery across the textile value chain. Its business mix also includes healthcare and biomedical technology initiatives, adding a broader industrial and service-oriented profile to its current operations.

CEO Mr. Pijun Liu · 7 employees · Hong Kong · https://newbrandcashmere.com